Letrozole 0.0025 N30 tablet
Active substances: Letrozole
Country of origin: Spain
Manufacturer: Kern Pharma S.L.
Release form: Tablets, film-coated, 2.5 mg each - 30 pcs per pack
- early stages of breast cancer expressing estrogen receptors in postmenopausal women as adjuvant therapy;
- early stages of breast cancer in postmenopausal women after completion of standard adjuvant therapy with tamoxifen as an extended adjuvant therapy;
- common hormone-dependent forms of breast cancer in postmenopausal women - first-line therapy;
- Common forms of breast cancer in postmenopausal women (natural or artificially induced) who have received prior antiestrogen therapy.